Bitting RL - Search Results

1

Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.

Dhar S, Bitting RL, Rylova SN, Jansen PJ, Lockhart E, Koeberl DD, Amalfitano A, Boustany RM. Dhar S, et al. Among authors: bitting rl. Ann Neurol. 2002 Apr;51(4):448-66. doi: 10.1002/ana.10143. Ann Neurol. 2002. PMID: 11921051

2

The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis.

Bitting RL, Bent S, Li Y, Kohlwes J. Bitting RL, et al. Blood Coagul Fibrinolysis. 2009 Oct;20(7):517-23. doi: 10.1097/MBC.0b013e32832ca388. Blood Coagul Fibrinolysis. 2009. PMID: 19644360 Review.

3

Therapy for non-clear cell histologies in renal cancer.

Bitting RL, Madden J, Armstrong AJ. Bitting RL, et al. Curr Clin Pharmacol. 2011 Aug;6(3):169-80. doi: 10.2174/157488411797189460. Curr Clin Pharmacol. 2011. PMID: 21861801 Review.

4

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide.

Noonan KL, North S, Bitting RL, Armstrong AJ, Ellard SL, Chi KN. Noonan KL, et al. Among authors: bitting rl. Ann Oncol. 2013 Jul;24(7):1802-1807. doi: 10.1093/annonc/mdt138. Epub 2013 Apr 12. Ann Oncol. 2013. PMID: 23585511 Free article.

5

Development of a method to isolate circulating tumor cells using mesenchymal-based capture.

Bitting RL, Boominathan R, Rao C, Kemeny G, Foulk B, Garcia-Blanco MA, Connelly M, Armstrong AJ. Bitting RL, et al. Methods. 2013 Dec 1;64(2):129-36. doi: 10.1016/j.ymeth.2013.06.034. Epub 2013 Jul 9. Methods. 2013. PMID: 23845299 Free PMC article.

6

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. Armstrong AJ, et al. Among authors: bitting rl. Mol Cancer Res. 2011 Aug;9(8):997-1007. doi: 10.1158/1541-7786.MCR-10-0490. Epub 2011 Jun 10. Mol Cancer Res. 2011. PMID: 21665936 Free PMC article.

7

Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?

Bitting RL, Armstrong AJ, George DJ. Bitting RL, et al. Clin Med Insights Oncol. 2011;5:325-32. doi: 10.4137/CMO.S5977. Epub 2011 Oct 20. Clin Med Insights Oncol. 2011. PMID: 22084621 Free PMC article.

8

Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancer.

Bitting RL, Armstrong AJ. Bitting RL, et al. Cancer J. 2013 Jan-Feb;19(1):25-33. doi: 10.1097/PPO.0b013e31827e0b9c. Cancer J. 2013. PMID: 23337754 Review.

9

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.

Bitting RL, Armstrong AJ. Bitting RL, et al. Endocr Relat Cancer. 2013 May 20;20(3):R83-99. doi: 10.1530/ERC-12-0394. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23456430 Review.

10

A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer.

Armstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, Embree E, Morris K, Winters C, Jaffe T, Fleming M, George DJ. Armstrong AJ, et al. Among authors: bitting rl. Clin Genitourin Cancer. 2013 Dec;11(4):397-406. doi: 10.1016/j.clgc.2013.05.007. Epub 2013 Jul 3. Clin Genitourin Cancer. 2013. PMID: 23830964 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters